These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8346719)

  • 1. Molecular genetic changes in human breast cancer.
    van de Vijver MJ
    Adv Cancer Res; 1993; 61():25-56. PubMed ID: 8346719
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytogenetic abnormalities, genetic alterations, and applications for genetic diagnosis in breast cancer].
    Tsukamoto K; Emi M; Nakamura Y
    Nihon Rinsho; 1996 Dec; 54(12):3389-97. PubMed ID: 8976125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability.
    Gretarsdottir S; Thorlacius S; Valgardsdottir R; Gudlaugsdottir S; Sigurdsson S; Steinarsdottir M; Jonasson JG; Anamthawat-Jonsson K; Eyfjörd JE
    Cancer Res; 1998 Mar; 58(5):859-62. PubMed ID: 9500438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
    Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
    Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Demonstration of two regions involved in chromosome 1p deletion in breast tumors].
    Bièche I; Champème MH; Matifas F; Cropp C; Callahan R; Lidereau R
    Bull Cancer; 1994 Feb; 81(2):108-13. PubMed ID: 7894115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common genetic pathways in breast oncogenesis.
    Callahan R; Gallahan D; Smith G; Cropp C; Merlo G; Venesio T; Liscia D; Lidereau R
    Pathol Biol (Paris); 1992 Nov; 39(9):910-1. PubMed ID: 1538928
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cancer of the breast. Genetic alterations and prognostic factors].
    Bièche I; Champème MH; Lidereau R
    Pathol Biol (Paris); 1990 Sep; 38(7):727-34. PubMed ID: 2235089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer gene offers surprises.
    Nowak R
    Science; 1994 Sep; 265(5180):1796-9. PubMed ID: 8091205
    [No Abstract]   [Full Text] [Related]  

  • 9. Mutational and promoter hypermethylation status of FHIT gene in breast cancer patients of Kashmir.
    Syeed N; Husain SA; Sameer AS; Chowdhri NA; Siddiqi MA
    Mutat Res; 2011 Feb; 707(1-2):1-8. PubMed ID: 21095196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome 11q13 abnormalities in human breast cancer.
    Fantl V; Smith R; Brookes S; Dickson C; Peters G
    Cancer Surv; 1993; 18():77-94. PubMed ID: 8013002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk assessment for familial occurrence of breast cancer].
    Chang-Claude J; Becher H; Hamann U; Schroeder-Kurth T
    Zentralbl Gynakol; 1995; 117(8):423-34. PubMed ID: 7571905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FHIT in human cancer.
    Sozzi G; Huebner K; Croce CM
    Adv Cancer Res; 1998; 74():141-66. PubMed ID: 9561268
    [No Abstract]   [Full Text] [Related]  

  • 13. Chromosome aberrations and cancer.
    Solomon E; Borrow J; Goddard AD
    Science; 1991 Nov; 254(5035):1153-60. PubMed ID: 1957167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel genetic aberrations in breast phyllodes tumours: comparison between prognostically distinct groups.
    Tan WJ; Lai JC; Thike AA; Lim JC; Tan SY; Koh VC; Lim TH; Bay BH; Tan MH; Tan PH
    Breast Cancer Res Treat; 2014 Jun; 145(3):635-45. PubMed ID: 24831776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The key and the lamppost.
    Hellman S
    J Clin Oncol; 1999 Oct; 17(10):3007-8. PubMed ID: 10506593
    [No Abstract]   [Full Text] [Related]  

  • 16. The molecular and genetic characterization of human soft tissue tumors.
    Cooper CS
    Adv Cancer Res; 1993; 60():75-120. PubMed ID: 8417503
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acquired genetic abnormalities in cancer of the breast].
    Lidereau R
    Rev Prat; 1990 Nov; 40(26):2468-72. PubMed ID: 2277941
    [No Abstract]   [Full Text] [Related]  

  • 18. Interphase cytogenetic analysis of erbB2 and topoII alpha co-amplification in invasive breast cancer and polysomy of chromosome 17 in ductal carcinoma in situ.
    Murphy DS; McHardy P; Coutts J; Mallon EA; George WD; Kaye SB; Brown R; Keith WN
    Int J Cancer; 1995 Feb; 64(1):18-26. PubMed ID: 7665243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genetics of breast cancer susceptibility.
    Rahman N; Stratton MR
    Annu Rev Genet; 1998; 32():95-121. PubMed ID: 9928476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of rarity of chromosome 17 polysomy in breast cancer.
    Moelans CB; Reis-Filho JS; van Diest PJ
    Lancet Oncol; 2011 Nov; 12(12):1087-9. PubMed ID: 21903472
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.